Ping An was established in Shenzhen in 1988 as a small insurance company with only 13 employees. Since then, Ping An has now grown remarkably into an integrated financial group which holds not only insurance business, but banking, investment and internet businesses with more than 1.7 million employees covering all China, ranking No.39 in “Fortune Global 500” in 2017.
| Company Name | Ping An Insurance (Group) Company of China, Ltd. |
|---|---|
| Headquarters | Shenzhen, China |
| Established | 1988 |
| Chairman & CEO | Ma Mingzhe |
| Business | Insurance, banking, investment and internet financial services |
| Total Assets | CNY6,493,075 million |
| Revenue | CNY974,570 million *FY2017 |
| Employees | 342,600 full-time, 1,380,000 sales agents |
| Rankings | Global No.39 (Fortune Global 500 in 2017) Global No.16 (Forbes 2000 in 2017) |
It is a leading company group in consumer products which holds 18 group companies including wholly-owned and minority-owned companies. Shanghai Jahwa United Co., Ltd. (listed on Shanghai Stock Exchange) is a manufacturer of sanitary materials, cosmetics and household chemical goods, leading in the Chinese cosmetics market.
The company operates the China’s greatest e-commerce site for consumers, substituting supermarkets and department stores. Walmart, seeking its international strategy, has acquired 100% stake of the company.
The company is ranked No.2 in the Chinese real estate market. As an integrated company group, the major business of which is real estate, it is ranked at the top in China. In the housing market, the company’s quality is highly evaluated at the top level.
WuXi PharmaTech is a leading R&D service provider for development of medicine, bio and medical equipment. Its customers include Pfizer, Merck, AstraZeneca, Novartis, Genentech, etc.
Yunnan Baiyao Group is the Chinese best-known medical company located in Yunnan. Not only is it large in size, but also holds prominent positions in terms of brands and total company power in China.
The company provides medical examination and health screening services in the largest size in China. It operates totally 200 medical centers in 44 cities in 29 provinces, far surpassing other companies in size.
The company operates private hospitals in Beijing, Shanghai, Hangzhou, etc., providing high-quality medical service specializing in gynecology and pediatrics.
The company operates private hospitals in Shanghai, providing high-quality medical service specializing in gynecology and pediatrics.
The company provides a China’s No.1 platform for diabetes management, connecting smart devices and patients. It has strategic alliances with insurance companies, blood-glucose measuring equipment manufacturers and drug shops.
The company is a national top DNA testing company, differentiating itself by brand and technology. It has already begun sales promotion to Ping An customers to gain awareness.
It is the top company in ERP for hospitals and resource management system in regional medicine. It has gained more than 1,200 customers in 12 years, 322 of which is large hospitals.
It is often compared with Flatiron Health in the U.S. It has the largest database of tumors, covering 20 types of tumor, coordinating with 243 hospitals specializing in tumors and managing more than 70,000 clinical records.
The company provides a B2B platform for 100,000 drug shops to buy/sell medicine. The monthly transaction value is CHY500 million.
It has developed a new method of oral administration of polymer medicine, substituting injection. Its first success was oral administration of insulin. Google, Ping An, Novartis, KPC Pharmaceuticals, etc. have invested into the company.
It has developed a product which enables speedy testing of small amount of blood. The investment is co-investment with Lab corp, Fuson, etc.
It is a Israeli company which develops small device under the skin to continuously measure blood glucose.